The mechanisms contributing to increased expression of CX3CR1 in hypoxic conditions may involve HIF-1-dependent and NF-κB-dependent signaling pathways, as shown in prostate cancer cells [40]. This evidence concerns the gene CX3CR1 and prostate carcinoma.